CD10+ fibroblasts also slightly enhanced the invasiveness of CD133− cancer cells more than CD10− fibroblasts, but significantly less than their effect on the invasiveness of CD133+ cancer cells (P<0.001; Figure 3C). Here, PROM1 is linked to cancer.